2020
DOI: 10.1136/annrheumdis-2020-218986
|View full text |Cite
|
Sign up to set email alerts
|

2020 EULAR points to consider for the prevention, screening, assessment and management of non-adherence to treatment in people with rheumatic and musculoskeletal diseases for use in clinical practice

Abstract: BackgroundNon-adherence to treatment could preclude reaching an optimal outcome. Thirty to 80% of patients with rheumatic and musculoskeletal diseases (RMDs) do not adhere to the agreed treatment.ObjectivesThe objective was to establish points to consider (PtCs) for the prevention, screening, assessment and management of non-adherence to (non-)pharmacological treatments in people with RMDs.MethodsAn EULAR task force (TF) was established, and the EULAR standardised operating procedures for the development of Pt… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
33
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 35 publications
(37 citation statements)
references
References 50 publications
4
33
0
Order By: Relevance
“…To account for this individuality, the interventions should be tailored to the patient’s needs. 80 In our results, 81 (72%) of the described face-to-face interventions showed such a tailored approach. However, only 7 out of 15 (47%) e-health programmes were tailored, which indicates a need for development of innovative tools and strategies to facilitate personalisation of these interventions.…”
Section: Discussionsupporting
confidence: 53%
“…To account for this individuality, the interventions should be tailored to the patient’s needs. 80 In our results, 81 (72%) of the described face-to-face interventions showed such a tailored approach. However, only 7 out of 15 (47%) e-health programmes were tailored, which indicates a need for development of innovative tools and strategies to facilitate personalisation of these interventions.…”
Section: Discussionsupporting
confidence: 53%
“…26 The taskforce considers treatment adherence (and discussions addressing this) to be part of the patient education plan. 31 Patient organisations reinforce the information and messaging about adherence and the impact of peer reinforcement around adherence is very powerful.…”
Section: Resultsmentioning
confidence: 99%
“…26 The taskforce considers treatment adherence (and discussions addressing this) to be part of the patient education plan. 31 Patient organisations reinforce the information and messaging about adherence and the impact of peer reinforcement around adherence is very powerful. EULAR has produced recommendations for patient education for people with IA addressing when and by whom patient education should be offered, as well as modes and methods of delivery, theoretical frameworks, outcomes and evaluation.…”
Section: Mean (Sd) % With Score ≥8mentioning
confidence: 99%
“…31 Around 3 decades past the introduction of bDMARDs, the rheumatologic community has proposed concepts of patient empowerment and self-management alongside or integrated in patient-centered care. 16,28,32,33 Active and effective implementation of these concepts in daily routine care is already overdue and remains one of the greatest challenges. The goal elicitation tool by Kahler el al 23 is a step toward better patient-HCP communication, which is at the epicenter of shared decision making and, therefore, of the effective management of patients with RA.…”
Section: Editorialmentioning
confidence: 99%